Diseases, Conditions, Syndromes

Denosumab promising for TDT-induced osteoporosis treatment

(HealthDay)—Denosumab (DNM), a fully human monoclonal antibody against the receptor activator of nuclear factor kappa-B ligand (RANKL), may be beneficial for managing transfusion-dependent thalassemia (TDT)-induced osteoporosis, ...

Diseases, Conditions, Syndromes

Drop in osteoporosis treatment initiation after hip fracture

(HealthDay)—In recent years there have been low rates of osteoporosis treatment initiation after a hip fracture, according to research published in the July 20 issue of JAMA Network Open.

Cardiology

Osteoporosis drug may benefit heart health

The osteoporosis drug alendronate was linked with a reduced risk of cardiovascular death, heart attack, and stroke in a Journal of Bone and Mineral Research study of patients with hip fractures. The association was seen for ...

Health

Exercise, not vitamins, urged to prevent falls in seniors

Falling is the leading cause of injury-related death among people over age 65, and seniors who want to avoid falls should exercise, not rely on supplements like vitamin D, US guidelines said Tuesday.

Medical research

Reversing severe bone loss

A possible first-line treatment for a rare bone loss disease has been identified by a research team led by Tohoku University in Japan. The research findings, published in the journal Molecular Cell, could also provide insight ...

Diseases, Conditions, Syndromes

Bone strength + bone mineral density screening cost-effective

(HealthDay)—Combined assessment of bone strength and bone mineral density is a cost-effective strategy for osteoporosis screening in postmenopausal women, according to a study published in the November issue of Radiology.

page 11 from 38